Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Munzel

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
European Heart Journal|April 15, 2015
German Society of Cardiology criteria for establishing chest pain unitsThomas Munzel
International Journal of Cardiology|January 1, 2014
Antibodies against biologicals and acute coronary syndromesTommaso Gori, Thomas Munzel
Journal of the American College of Cardiology|June 25, 2003
The failing human heart: another battlefield for the NAD(P)H oxidase?Ascan Warnholtz, Thomas Munzel
European Heart Journal|September 29, 2015
Environmental hazards, air pollution, and noise as novel cardiovascular risk factorsThomas Munzel, Frank Schmidt, Tommaso Gori
European Heart Journal|April 22, 2026
Europe's heat and fire crisis and the new fossil-fuel surge from artificial intelligenceSanjay Rajagopalan, Thomas Munzel, Antonio Gasparrini
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 31, 2006
Electron paramagnetic resonance (EPR) spin trapping of biological nitric oxideAndrei L Kleschyov, Philip Wenzel, Thomas Munzel
Circulation|June 26, 2002
Heme oxygenase-1-mediated protection: potential role of nonheme iron-nitric oxide complexesAndrei L Kleschyov, Maria Wendt, Thomas Munzel
Clinical Hemorheology and Microcirculation|January 5, 2012
Endothelium and hyperviscositySandro Forconi, Philip Wild, Thomas Munzel, et al.
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Inflammatory markers and cardiovascular risk in the metabolic syndromeChristine Espinola-Klein, Tommaso Gori, Stefan Blankenberg, et al.
Minerva Cardioangiologica|February 7, 2019
Incidence of infective endocarditis before and after the guideline modification regarding a more restrictive use of prophylactic antibiotics therapy in the USA and EuropeKarsten Keller, Lukas Hobohm, Thomas Munzel, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
European Heart Journal|April 15, 2015
German Society of Cardiology criteria for establishing chest pain unitsThomas Munzel
International Journal of Cardiology|January 1, 2014
Antibodies against biologicals and acute coronary syndromesTommaso Gori, Thomas Munzel
Journal of the American College of Cardiology|June 25, 2003
The failing human heart: another battlefield for the NAD(P)H oxidase?Ascan Warnholtz, Thomas Munzel
European Heart Journal|September 29, 2015
Environmental hazards, air pollution, and noise as novel cardiovascular risk factorsThomas Munzel, Frank Schmidt, Tommaso Gori
European Heart Journal|April 22, 2026
Europe's heat and fire crisis and the new fossil-fuel surge from artificial intelligenceSanjay Rajagopalan, Thomas Munzel, Antonio Gasparrini
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 31, 2006
Electron paramagnetic resonance (EPR) spin trapping of biological nitric oxideAndrei L Kleschyov, Philip Wenzel, Thomas Munzel
Circulation|June 26, 2002
Heme oxygenase-1-mediated protection: potential role of nonheme iron-nitric oxide complexesAndrei L Kleschyov, Maria Wendt, Thomas Munzel
Clinical Hemorheology and Microcirculation|January 5, 2012
Endothelium and hyperviscositySandro Forconi, Philip Wild, Thomas Munzel, et al.
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Inflammatory markers and cardiovascular risk in the metabolic syndromeChristine Espinola-Klein, Tommaso Gori, Stefan Blankenberg, et al.
Minerva Cardioangiologica|February 7, 2019
Incidence of infective endocarditis before and after the guideline modification regarding a more restrictive use of prophylactic antibiotics therapy in the USA and EuropeKarsten Keller, Lukas Hobohm, Thomas Munzel, et al.
Pageof 9